News

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in ...
Ring Clear is an all-natural tinnitus supplement drawing 2025 attention in the inner ear wellness space. It combines 12 plant ...
FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.
Welcome to the Money blog, Sky News's personal finance and consumer hub. Today: a reader in a dispute with TK Maxx asks for ...
Get the scoop of the return of the magnificent moa, a giant flightless bird in New Zealand that went extinct centuries ago.
The royal family was out in force today to greet France's President Emmanuel Macron and First Lady Brigitte Macron at the ...
Kesha may now be a free and independent artist, but up until just a couple of years ago, she was contractually obligated to work with the same person she was suing on allegations of sexual assault.
Submission is based on long-term Phase 3 data demonstrating 63 percent reduction in risk of relapse in adults with schizophrenia compared to placebo CAPLYTA® is FDA ...
Topline data expected in H2 2026 LONDON and CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited ("Beacon Therapeutics" or "the Company"), a leading clinical-stage ...
PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 1500 Health Care Index returned 5.5% in the first quarter, ...
Jasper Therapeutics’ stock has dropped by more than 50% after the company announced it was looking into the impact of a ...
Dosing of the first patient in Phase 2b marks an important transition of the RESOLVE trial from a Phase 2a open-label study ...